发明名称 SATB1: A DETERMINANT OF MORPHOGENESIS AND TUMOR METASTATIS
摘要 It is proposed that cancer cells express SATB1, and that SATB1 acts as a determinant for the acquisition of metastatic activity by controlling expression of a specific set of genes that promote metastatic activity. In order for cancer cells to gain the ability to metastasize, SATB1 re-organizes or re-packages genomic sequences in a specific manner to allow a switch in the pattern of gene expression. SATB1 expression was found restricted mainly to aggressive cancer cells where it may regulate the genetic and epigenetic changes that program the steps involved in the metastatic process. The present invention describes reagents and tools to detect the SATB1 protein for use in diagnosis and prognosis of aggressive cancers and therapeutics to inhibit SATB1 protein to deplete its expression in metastatic and aggressive cancers.
申请公布号 US2015323536(A1) 申请公布日期 2015.11.12
申请号 US201414540991 申请日期 2014.11.13
申请人 The Regents of the University of California 发明人 Kohwi-Shigematsu Terumi;Han Hye-Jung;Kohwi Yoshinori
分类号 G01N33/574;C12N15/113;A61K31/7105;C07K16/18;C12N15/115;C12Q1/68;A61K31/713 主分类号 G01N33/574
代理机构 代理人
主权项 1. A prognostic method for identifying a patient that has a cancer that is a candidate for aggressive treatment, said method comprising: providing a primary tumor tissue biopsy from a patient; detecting SATB1 expression, whereby said detection of SATB1 expression is a predictor or marker of that the cancer is aggressive.
地址 Oakland CA US